NEWSROOM
News & Stories
Newsroom
Press Releases
FOCUS Study Shows MammaPrint Accurately Identifies Extremely Indolent Cancers
Findings confirm subanalysis of STO-3 trial and provide foundation for consideration of de-escalation of treatment in post-menopausal patients guided by genomic testing IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – December 9, 2020 – Agendia, Inc., Read More
Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer
Co-development program will utilize next-generation digital pathology platform and AI-based technology to provide real-time genomic testing results Partnership to create new products enabling faster access to predictive information in treatment planning for patients with breast Read More
Agendia to Showcase Robust Clinical Research at SABCS 2020 Emphasizing Need for Diversity of Data to Treat Breast Cancer Patients
Variety of data confirm the importance of applying genomic analysis to explore and improve outcomes for subpopulations of breast cancer patients IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – NOVEMBER 17, 2020 – Agendia, Inc., a Read More